首页> 美国卫生研究院文献>other >The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypes
【2h】

The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypes

机译:HSC激活的机制和HSC表型的表观遗传调控

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Epigenetics is a dynamically expanding field of science entailing numerous regulatory mechanisms controlling changes of gene expression in response to environmental factors. Over the recent years there has been a great interest in epigenetic marks as a potential diagnostic and prognostic tool or future target for treatment of various human diseases. There is an increasing body of published research to suggest that epigenetic events regulate progression of chronic liver disease. Experimental manipulation of epigenetic signatures such as DNA methylation, histone acetylation / methylation and the activities of proteins that either annotate or interpret these epigenetic marks can have profound effects on the activation and phenotype of HSC, key cells responsible for onset and progression of liver fibrosis. This review presents recent advances in epigenetic alterations, which could provide mechanistic insight into the pathogenesis of chronic liver disease and provide novel clinical applications.
机译:表观遗传学是一个动态扩展的科学领域,需要众多的调节机制来控制响应环境因素的基因表达变化。近年来,人们对表观遗传标记作为治疗各种人类疾病的潜在诊断和预后工具或未来目标有了极大的兴趣。越来越多的已发表研究表明表观遗传事件调节慢性肝病的进展。表观遗传学特征的实验性操作,例如DNA甲基化,组蛋白乙酰化/甲基化以及注释或解释这些表观遗传学标志的蛋白质活性,可对HSC,负责肝纤维化发作和发展的关键细胞的激活和表型产生深远影响。这篇综述介绍了表观遗传学改变的最新进展,可以为慢性肝病的发病机理提供机制上的见识,并提供新颖的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号